🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study the safety and effectiveness of oral AT-101 when ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT00934076
Treatments Being Tested
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
The purpose of this study is to evaluate the combination of Pegylated Alfa ...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-05
Trial ID
NCT00522249
Treatments Being Tested
Patient selection: a) Pathological confirmation of non-small cell lung canc...
Status
Terminated
Location
Geisel School of Medicine at Dartmouth
Start Date
2016-12-07
Trial ID
NCT02991651
The purpose of this study is to determine whether erlotinib plus pemetrexed...
Status
Completed
Location
The first affiliated hospital of Guangzhou MC
Start Date
2012-01
Trial ID
NCT01578668
Treatments Being Tested
1. Title and stage of study A Phase II Study to Assess Efficacy of Combined...
Status
Unknown
Location
Gosin University Gospel Hospital
Start Date
2014-04
Trial ID
NCT02146118
Treatments Being Tested
This multicenter, observational study will evaluate the efficacy and safety...
Status
Completed
Location
Clinical Center of Serbia; Institute For Pulmology
Start Date
2013-05
Trial ID
NCT01836133
Treatments Being Tested
This 2 arms study will compare the efficacy and safety of treatment with se...
Status
Completed
Location
Service de Pneumologie, CHU Angers
Start Date
2011-06
Trial ID
NCT01350817
Treatments Being Tested
Both pemetrexed and erlotinib are second-line treatment options for patient...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2008-12
Trial ID
NCT01565538
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested